Literature DB >> 18828857

Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in New Caledonia.

S Le Hello1, V Falcot, F Lacassin, F Baumann, P Nordmann, T Naas.   

Abstract

Carbapenem-resistant Acinetobacter baumannii (CR-Ab) ranked third, with a frequency of 24.8%, among 202 strains of multidrug-resistant bacteria isolated from clinical samples in the main hospital of New Caledonia in 2004. All CR-Ab isolates were analysed by isoelectric focusing, conjugation, pulsed-field gel electrophoresis and PCR for the presence of carbapenemase genes. Fifty CR-Ab isolates produced carbapenemase OXA-23. The isolates belonged to a single clone presenting several subtypes, suggesting an endemic situation. This study further illustrates the widespread prevalence of carbapenemase OXA-23-producing CR-Ab isolates in the South Pacific.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18828857     DOI: 10.1111/j.1469-0691.2008.02068.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  4 in total

1.  First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.

Authors:  Delphine Girlich; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

2.  First detection of OXA-24 carbapenemase-producing Acinetobacter baumannii isolates in Bulgaria.

Authors:  Bozhana Todorova; Tzvetan Velinov; Ivan Ivanov; Elina Dobreva; Todor Kantardjiev
Journal:  World J Microbiol Biotechnol       Date:  2013-11-28       Impact factor: 3.312

3.  Carbapenem-resistant Acinetobacter baumannii from Air and Patients of Intensive Care Units.

Authors:  Meijie Jiang; Yunqing Mu; Ning Li; Zhijun Zhang; Shulin Han
Journal:  Pol J Microbiol       Date:  2018

4.  Bacteriology and Antimicrobial Resistance in Vanuatu: January 2017 to December 2019.

Authors:  Nicola D Foxlee; Nicola Townell; Mary Ann L Tosul; Lachlan McIver; Colleen L Lau
Journal:  Antibiotics (Basel)       Date:  2020-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.